← Return to Forteo (teriparatide) followed by HRT: My Experience

Discussion
Comment receiving replies
Profile picture for debbie1956 @debbie1956

@mayblin These results are stunning and so encouraging! Thanks you for posting them. You must be thrilled! If I understand correctly, it appears you continued to gain from spine -2.9 to -1.9 after 15 months on BHRT without reclast or other bisphosphonate, and your CTX reduced to 110-130 pg/ml six months after starting BHRT. What was your CTX prior to to the BHRT? As I recall you have never fractured. Our histories are very similar with my DEXA score two years ago at spine at -3.5. I later started the same dose of BHRT as you around the same time at age 67, 13 years post menopause. As I previously posted, my recent CTX showed a 90% drop from 688 pg/ml to .99 after 14 months on BHRT. I am hopeful looking at your amazing results that I may gain a little more BMD still as my REMS showed an increase from -3 to -2.6 after 10 months on BHRT. I will post my next DEXA/TBS results. It is good to know that the Forteo worked well for you should I need to take it. Thanks again for sharing and congratulations!

Jump to this post


Replies to "@mayblin These results are stunning and so encouraging! Thanks you for posting them. You must be..."

Thanks so much Debbie, your kind words mean a lot!

I’m glad you asked about the details - I think they’re important. My CTX was 793 at the end of Forteo, showing a high-turnover state, though I’m not sure how much that drove the improvements. I transitioned directly from Forteo to HRT without a bisphosphonate, and my T-scores continued to rise: lumbar spine –2.9 to –1.9, with other sites also improving over 15 months on HRT.

While estrogen isn’t a bone builder by itself, it helped maintain and even add to BMD gains in my case. My P1NP was still high at the end of Forteo, carrying into the HRT period. Between the last two DXA scans (month 7 thru 15 on HRT), I also used three leftover Forteo pens alongside HRT, which may have contributed to additional gains (lumbar +5.3%), even though CTX was 110–130 and P1NP had a notable percentage rise despite a small absolute change (25 to 33)

These data are fascinating. As more women use HRT, we’ll learn a lot about how it interacts with anabolic therapy in different sequences or combinations.

I’m looking forward to seeing your new DXA results with TBS! Fingers crossed!